Identification Generic Name (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL DrugBank Accession Number DB07648 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL (DB07648) ×  Close Weight Average: 360.4091  Monoisotopic: 360.158625904  Chemical Formula C 21 H 20 N 4 O 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Serine/threonine-protein kinase Chk1 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as phenylpyrroles. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrrole ring through a CC or CN bond. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Pyrroles Sub Class Substituted pyrroles Direct Parent Phenylpyrroles Alternative Parents Pyrrolo[2,3-d]pyrimidines  /  Secondary alkylarylamines  /  Aminopyrimidines and derivatives  /  Imidolactams  /  Benzene and substituted derivatives  /  Heteroaromatic compounds  /  Secondary alcohols  /  1,2-diols  /  Azacyclic compounds  /  Primary alcohols  /  Organopnictogen compounds  /  Hydrocarbon derivatives 
 
 
  show 2 more Substituents 1,2-diol  /  2-phenylpyrrole  /  3-phenylpyrrole  /  Alcohol  /  Amine  /  Aminopyrimidine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imidolactam  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary alcohol  /  Pyrimidine  /  Pyrrolo[2,3-d]pyrimidine  /  Pyrrolopyrimidine  /  Secondary alcohol  /  Secondary aliphatic/aromatic amine  /  Secondary amine 
 
 
  show 15 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors pyrrolopyrimidine ( CHEBI:41839 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key TWEONIHFGKSPLC-MRXNPFEDSA-N InChI InChI=1S/C21H20N4O2/c26-12-16(27)11-22-20-18-17(14-7-3-1-4-8-14)19(15-9-5-2-6-10-15)25-21(18)24-13-23-20/h1-10,13,16,26-27H,11-12H2,(H2,22,23,24,25)/t16-/m1/s1 IUPAC Name (2R)-3-({5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)propane-1,2-diol SMILES [H][C@](O)(CO)CNC1=C2C(NC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1 References General References Not Available External Links PubChem Compound 4369435 PubChem Substance 99444119 ChemSpider 3571997 ZINC ZINC000006475920 PDBe Ligand DF2 PDB Entries 2bro Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0275 mg/mL ALOGPS logP 2.58 ALOGPS logP 2.48 Chemaxon logS -4.1 ALOGPS pKa (Strongest Acidic) 12.27 Chemaxon pKa (Strongest Basic) 6.31 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 94.06 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 106.67 m 3 ·mol -1 Chemaxon Polarizability 38.77 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9902 Blood Brain Barrier + 0.871 Caco-2 permeable - 0.5937 P-glycoprotein substrate Non-substrate 0.5639 P-glycoprotein inhibitor I Non-inhibitor 0.7941 P-glycoprotein inhibitor II Non-inhibitor 0.5406 Renal organic cation transporter Non-inhibitor 0.8582 CYP450 2C9 substrate Non-substrate 0.8155 CYP450 2D6 substrate Non-substrate 0.7522 CYP450 3A4 substrate Non-substrate 0.7002 CYP450 1A2 substrate Non-inhibitor 0.7163 CYP450 2C9 inhibitor Non-inhibitor 0.767 CYP450 2D6 inhibitor Non-inhibitor 0.7785 CYP450 2C19 inhibitor Non-inhibitor 0.6536 CYP450 3A4 inhibitor Non-inhibitor 0.6889 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.5265 Ames test Non AMES toxic 0.6437 Carcinogenicity Non-carcinogens 0.871 Biodegradation Not ready biodegradable 0.9717 Rat acute toxicity 2.5901 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9449 hERG inhibition (predictor II) Inhibitor 0.5831    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Serine/threonine-protein kinase Chk1 Kind Protein Organism Humans Pharmacological action Unknown General Function Protein serine/threonine kinase activity Specific Function Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also nega... Gene Name CHEK1 Uniprot ID O14757 Uniprot Name Serine/threonine-protein kinase Chk1 Molecular Weight 54433.115 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:24 / Updated at June 12, 2020 16:52 